Resource

 

 

 

 

 

 

 

 

 

 

 

Davis Polk Advises iKang Healthcare on Its Acquisition by Yunfeng Capital and Alibaba

04 Apr 2018

Davis Polk is advising iKang Healthcare Group, Inc. in connection with its acquisition for $41.20 per common share or $20.60 per American Depository Share by a consortium consisting of certain funds affiliated with Yunfeng Capital, Alibaba Group Holding Limited and certain of iKang’s senior management. The transaction is subject to customary closing conditions, including approval by the shareholders of iKang and is expected to close in the third quarter of 2018.

Capital Square Partners’ Potential Equity Investment in StarTek, Inc. and Its Sale of Aegis to StarTek, Inc.

04 Apr 2018

Shearman & Sterling is advising Capital Square Partners in connection with its equity investment in StarTek, Inc. and its sale of Aegis, one of its subsidiaries, to StarTek as consideration for such equity investment. Immediately following the consummation of the transactions, Aegis will become a wholly owned subsidiary of StarTek, and Capital Square Partners is expected to hold a majority stake of StarTek’s outstanding common stock. The closing o    f the transactions is conditional on stockholder approval of StarTek and customary regulatory approvals.

Herbert Smith Freehills advises arrangers on acquisition financing for GlaxoSmithKline

04 Apr 2018

HSF London's finance team has advised the mandated lead arrangers on their successful acquisition financing for GlaxoSmithKline's $13 billion buyout of Novartis' 36.5% stake in their consumer healthcare joint venture.

The team involved in negotiating the financing was led by partner Will Nevin with the assistance of senior associate Elliot Beard and key associates Oliver Henderson and Ben Robinson.

Stephenson Harwood advises SMBC Group on investment loan refinancing of retail elements at Centre Point

04 Apr 2018

Stephenson Harwood LLP has advised Sumitomo Mitsui Banking Corporation Europe Limited – part of the SMBC Group – on a bilateral investment facility, provided by SMBC Group to Almacantar, secured on the retail elements of Centre Point.

The provision of this facility by SMBC Group, a global provider of commercial banking services, to Almacantar, a property investment and development company, follows the successful development by Almacantar of the iconic tower.

Advising Moog

04 Apr 2018

International law firm Simmons & Simmons has advised the US based, Moog Inc. on the acquisition of the Czech/German company Vues Brno. The transaction was completed at the end of March 2018 for a purchase price of $53m.
The team, led by partner, Stephan Ulrich, who is based in the firm’s Dusseldorf office, consisted of M&A lawyers from both Germany and the UK.

Moog Inc. is a worldwide designer, manufacturer and integrator of precision control components and systems. Vues designs and manufactures customized electric motors, generators and solutions.

Schulte Advises Veritas Capital and Its Affiliates in Acquisition of GE Healthcare Unit

04 Apr 2018

Schulte represented Veritas Capital and its affiliates in their acquisition of GE Healthcare’s enterprise financial management, ambulatory care management and workforce management assets comprising its value-based care division for $1.05 billion in cash. Veritas is a leading private equity firm that has made the healthcare technology space a key area of focus. Harnessing data and analytics across hardware, software and biotech, GE Healthcare is the $19 billion healthcare business of GE.

Osborne Clarke advises GP Bullhound Fund IV on SEK 25M equity investment in Quixel AB

04 Apr 2018

International legal practice Osborne Clarke has advised international venture capital fund, GP Bullhound Fund IV, on its SEK 25 million equity investment in Swedish company, Quixel AB.

Quixel AB develops tools for 3D artists, primarily in the video gaming and film industries. The company’s main product is Megascans, the world’s largest and fastest growing library of scanned 3D objects and materials. Co-investors in the financing round include Back in Black.

Freshfields advises Li & Fung on strategic divestment of three product verticals

04 Apr 2018

Freshfields Bruckhaus Deringer (‘Freshfields’) has advised Li & Fung Limited, the world’s leading supply chain solutions partner, on the strategic divestment of its furniture, beauty and sweaters product verticals to True Sage Limited, an investment holding company indirectly wholly-owned by Hony Capital, Fung Holdings (1937) Limited and Fung Investments Limited, for a total cash consideration of US$1.1bn, subject to post-closing adjustments. The strategic divestment completed on 3rd April 2018.